Medicine and Dentistry
Blood Donor
100%
Fecal Microbiota Transplantation
62%
Infection
58%
Severe Acute Respiratory Syndrome Coronavirus 2
29%
Placebo
27%
Quality of Life
22%
COVID-19
22%
Adverse Event
17%
Prospective Cohort Study
16%
Feces
16%
Major Depressive Episode
14%
Symptom
14%
Seroconversion
13%
Supplementation
13%
Plasmapheresis
13%
Neuropathy
13%
Patient with Type 1 Diabetes
13%
Seroprevalence
12%
Odds Ratio
11%
Depression
10%
Disease
10%
Dermatosis
10%
Prevalence
10%
Short Form 12
10%
Iron Deficiency
9%
Ferritin
9%
Cohort Analysis
9%
Rheumatic Disease
8%
Rheumatoid Arthritis
8%
Antibiotics
8%
Systemic Lupus Erythematosus
8%
Clostridium Difficile Infection
8%
Depression Inventory
8%
Helicobacter Pylori
8%
COVID-19 Vaccine
6%
Migraine
6%
Sex Difference
6%
Mortality Rate
6%
Antibody Screening
6%
Revaccination
6%
Cross Sectional Study
6%
Sulfate
6%
Aortic Stenosis
6%
Backache
6%
Malassezia
6%
Hidradenitis Suppurativa
6%
Acneiform Eruption
6%
Human Leukocyte Antigen
6%
C Reactive Protein
6%
Psoriasis
6%
Immunology and Microbiology
COVID-19
56%
Severe Acute Respiratory Syndrome Coronavirus 2
49%
Feces microflora
27%
Monospecific Antibody
25%
Seroconversion
21%
Mortality Rate
20%
Vaccination Policy
20%
Vaccine Efficacy
19%
Rheumatic Disease
15%
Rituximab
15%
Seroprevalence
15%
Immunoglobulin E
13%
Antibody Screening
13%
Human Leukocyte Antigen
13%
Leukocyte
13%
Sensitization
13%
B Cell
13%
Allergic Rhinitis
12%
Blood Plasma
12%
Prevalence
12%
Asthma
11%
Immunoglobulin G
11%
Allergic Conjunctivitis
10%
Mental Health
10%
Comorbidity
9%
Antibody Response
8%
Inflammatory Arthritis
7%
Systemic Lupus Erythematosus
7%
Immunoassay
7%
Autoantibodies
6%
Conjunctivitis
6%
Pylorus
6%
Intervertebral Disk
6%
Malassezia
6%
Omicron Coronavirus Variant
6%
Rhinitis
6%
Virus Nucleocapsid
6%
Helicobacter Pylori
6%
C-Reactive Protein
6%
Neutralization
6%
Hidradenitis Suppurativa
6%
Autoimmune Rheumatic Disease
6%
Chemokine
6%
Blood Level
6%
Staphylococcus Aureus
6%
Immunoglobulin M
5%
Allergic Asthma
5%
Allele
5%
T Cell
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
54%
Feces microflora
41%
SARS Coronavirus
23%
Rheumatic Disease
20%
Placebo
20%
Disease
18%
Symptom
14%
Coronavirinae
13%
Migraine
13%
Vaccination Policy
13%
Mortality Rate
13%
Insulin Dependent Diabetes Mellitus
13%
Neuropathy
13%
Seroprevalence
12%
Adverse Event
10%
Cohort Study
9%
Rituximab
8%
Antibiotic Agent
8%
Iron Deficiency
8%
Comorbidity
7%
Systemic Lupus Erythematosus
7%
Rheumatoid Arthritis
7%
Staphylococcal Infection
6%
Chemokine
6%
Hyperhidrosis
6%
mRNA Vaccine
6%
C Reactive Protein
6%
Staphylococcus Aureus
6%
Helicobacter Pylori
6%
Prospective Cohort Study
6%
Epidemic
6%
Gastrointestinal Symptom
5%
